Scientists of the Institute of Medical Virology in Frankfurt am Main (Germany) conducted a study of the antiviral effect of the drug against SARS-COV-2 virus in a cell model. The drug was tested on human cells infected with SARS-COV-2 Enisamium showed a good effect. This was the reason for starting clinical trials of the drug in Ukraine.
Upon successful completion of the tests, Amizon will be available in all countries where Farmak is present.
Clinical trials will last several months.
“Amizon” as an effective drug for the treatment of influenza and other SARS is already bought by patients in 11 countries – including Belarus, Kazakhstan, Uzbekistan and others.
Forbes published the rating of “100 largest private enterprises of Ukraine”. Farmak is the only pharmaceutical manufacturer that got into this list. Today Farmak is a leader of the pharmaceutical market with a 5.9% share. The medicinal products manufactured by the Company are presented in fourteen therapeutic groups. The portfolios mainly consist of anti-col...
Websites Transparency Index of Ukrainian companies-2019 was presented by the Professional Association of Corporate Governance in cooperation with the Center for Corporate Social Responsibility Development (CSR) with the support of CIPE and with the assistance of the Ministry of Economic Development, Trade and Agriculture of Ukraine. “The index is, first of...
TOP 100. The Ratings of the Largest published the Employer Brand Rating and the Rating of TOP 30 Best HR Directors in Ukraine. According to the magazine, Farmak is one of three companies providing the best working conditions, and Viktoria Kondrashykhina, HR Director of Farmak, became the best HR director in the pharmaceutical industry. The […]